Limits...
Infiltrating Ductal Carcinoma

Storm ESS - MedPix

View Article: MedPix Image - MedPix Case

Affiliation: Uniformed Services University

ABSTRACT

Diagnosis: Infiltrating Ductal Carcinoma

History: 32 year-old female, asymptomatic with respect to the breasts. Patient has a mother and sister with breast cancer before age 45. She is 10 months postpartum, is no longer lactating, but is trying to get pregnant.

Findings: Initial screening two view mammogram was negative for suspicious calcifications or mass. The brest tissue was heterogenously dense. Patient underwent routine screeing breast MR which demonstrates a small enhancing mass within the mid right breast, 12:00 position. There is minimal associated T2 hyperintensity, but this involves more the periphery of the lesion, rather than the substance of the lesion itslef. No other discordant foci of abnormal enhancement were present within either breast. The patient was recalled for subsequent right breast ultrasound. This demonstrates an angulated, hypoechoic 5mm mass in at the 12:00 position, zone 1a. Subsequent ultrasound-guided 14ga core biopsy was performed.

Ddx: Atypical fibroadenoma Ductal carcinoma in situ Infiltrating carcinoma Atypical lymph node Atypical papilloma Granular cell tumor

Dxhow: Core Biopsy

Exam: Negative clinical breast exam by experienced surgeon, negative screening mammography. Genetics testing revealed BRCA-1 positivity.

No MeSH data available.


A reigon of interest has been marked on the image to the left of the screen.  This corresponds to the kinetics graph on the right.  Note the rapid wash-in and wash-out.  This curve, through crude, is characteristic of a malignant breast lesion.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=MPX1324&req=5

MPX1324_synpic26183: A reigon of interest has been marked on the image to the left of the screen. This corresponds to the kinetics graph on the right. Note the rapid wash-in and wash-out. This curve, through crude, is characteristic of a malignant breast lesion.


Infiltrating Ductal Carcinoma

Storm ESS - MedPix

A reigon of interest has been marked on the image to the left of the screen.  This corresponds to the kinetics graph on the right.  Note the rapid wash-in and wash-out.  This curve, through crude, is characteristic of a malignant breast lesion.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=MPX1324&req=5

MPX1324_synpic26183: A reigon of interest has been marked on the image to the left of the screen. This corresponds to the kinetics graph on the right. Note the rapid wash-in and wash-out. This curve, through crude, is characteristic of a malignant breast lesion.

View Article: MedPix Image - MedPix Case

Affiliation: Uniformed Services University

ABSTRACT

Diagnosis: Infiltrating Ductal Carcinoma

History: 32 year-old female, asymptomatic with respect to the breasts. Patient has a mother and sister with breast cancer before age 45. She is 10 months postpartum, is no longer lactating, but is trying to get pregnant.

Findings: Initial screening two view mammogram was negative for suspicious calcifications or mass. The brest tissue was heterogenously dense. Patient underwent routine screeing breast MR which demonstrates a small enhancing mass within the mid right breast, 12:00 position. There is minimal associated T2 hyperintensity, but this involves more the periphery of the lesion, rather than the substance of the lesion itslef. No other discordant foci of abnormal enhancement were present within either breast. The patient was recalled for subsequent right breast ultrasound. This demonstrates an angulated, hypoechoic 5mm mass in at the 12:00 position, zone 1a. Subsequent ultrasound-guided 14ga core biopsy was performed.

Ddx: Atypical fibroadenoma Ductal carcinoma in situ Infiltrating carcinoma Atypical lymph node Atypical papilloma Granular cell tumor

Dxhow: Core Biopsy

Exam: Negative clinical breast exam by experienced surgeon, negative screening mammography. Genetics testing revealed BRCA-1 positivity.

No MeSH data available.